←Back to list

Saama Analytics

Developer of an enterprise platform intended to assist medical companies in assessing business risk decisions.
Developer of an enterprise platform intended to assist medical companies in assessing business risk decisions.
Enterprise Systems (Healthcare) 📍 Campbell, CA Founded 1997
Current Valuation
$565M
as of 2021-Q4
PRIVATE

QL Price

$565M
0% vs last round
QuantLogix's current estimate for Saama Analytics, published 2026-09-27 — in line with the last disclosed round of $565M (2021-Q4).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round $565M 2021-Q4 weight 0.04
How this price has held up
No round has priced for Saama Analytics since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Saama Analytics →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Saama Analytics, 2026-09-27 (b4cf3bb1fe4620c1). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is Saama Analytics going public?
No. Saama Analytics is private and has not filed to go public. There is no S-1 on file.
What is Saama Analytics' valuation in 2026?
Saama Analytics is valued at $565M as of 2021-Q4, set by its Series B ($215M, Nov 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Saama Analytics filed an S-1?
No public S-1 is on file for Saama Analytics.
How much has Saama Analytics raised?
Saama Analytics has raised $290.75M in total, most recently a Series B of $215M in Nov 2021.
Is Saama Analytics publicly traded — can you buy Saama Analytics stock?
No. Saama Analytics is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Saama Analytics on its Pre-IPO Access Desk.
How to actually get exposure to Saama Analytics →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

Founded
1997
HQ
Campbell, CA
Employees
1,853
Total Raised
$290.75M
Last Round
Series B — $215M (Nov 2021)
IPO Status
private

Fundraising Status

Series B · $215M · 4y 10mo ago
privateTotal raised $290.75M

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series B$215MNov 2021—$565M

Talent Signal

Hiring trend
▶ Hiring steady
-5% vs 2026-08
Open roles
40
via careers page
Product-build share
65%
engineering, research, product, design
Trajectory
steady
heavy product build — 65% of open roles are product-building functions (engineering/research/product) — 14 of 40 open roles are medical.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by month42Aug '2640Sep '26
Open roles by function
Open roles by functionClinical & Science14Sales & GTM5Data & ML5Engineering5Ops & People4Finance & Strategy3Marketing2Research1Design1
■ product-building   ■ go-to-market / G&A
Clinical Data FoundationSmart Medical CodingBiometrics Research and Analysis Information Network (BRAIN)Medical MonitorsClinical ProgrammersClinical Solutions
Counted from Saama Analytics's live job board as of 2026-09-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Business IntelligenceInformation TechnologyCloud Data ServicesPredictive AnalyticsMachine LearningArtificial Intelligence
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.